Next 10 |
TORONTO, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”),...
Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...
Merger activity increased last week with five new deals announced and six pending deals closing. Deal Statistics: New Deals: The acquisition of Advanced Disposal Services (ADSW) by Waste Management (WM) for $4.9 billion or $33.15 per share in cash. The acquisition of Electro...
Happy tax day and welcome to the latest edition of Merger Arbitrage Mondays. Merger activity increased last week with four new deals announced and two pending deals closing. We made a mistake last week when we indicated that the acquisition of Versum Materials (VSM) by Entegris (ENTG) closed...
MONTREAL, April 11, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that the Québec Superior Court issued earlier today a final order approving the previously announced statutory plan of arrangement u...
MONTREAL, April 09, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that its shareholders have approved the previously announced statutory plan of arrangement under the Canada Business Corporations Act ...
(Rendition of Brain Neurons, Source: NIH) The biotech sector has continued to participate in the market rally. One of the reasons is the strength in biopharma M&A activity, which provides unique support for valuations and particularly assists the small-and-midcap biotech companies. We ...
MONTREAL , March 7, 2019 /PRNewswire/ -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) is pleased to announce that it has obtained an interim order from the Québec Superior Court in connection with the previously announced plan of arrangement pursuant to which a wholly-owne...
Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and voting agreements with two additional significant shareholders Canada NewsWire MONTREAL, March 6, 2019 MONTREAL , March 6, 2019 /CNW Telbec/ - ...
Merger activity decreased last week with two new deals announced and six pending deals closing. Deal Statistics: New Deals: The acquisition of Clementia Pharmaceuticals ( CMTA ) by Ipsen for $1.31 billion. Under the terms of the agreement, shareholders of Clementia Pharmaceutica...
News, Short Squeeze, Breakout and More Instantly...
Clementia Pharmaceuticals Inc. Company Name:
CMTA Stock Symbol:
NASDAQ Market:
Clementia Pharmaceuticals Inc. Website:
TORONTO, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”),...
MONTREAL, April 11, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that the Québec Superior Court issued earlier today a final order approving the previously announced statutory plan of arrangement u...
MONTREAL, April 09, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that its shareholders have approved the previously announced statutory plan of arrangement under the Canada Business Corporations Act ...